MagVenture Inc., a provider of transcranial magnetic stimulation, has received clearance from the US Food and Drug Administration for a new protocol that cuts the time of each treatment session down to 3 minutes, the company announced.
The effectiveness of the vast majority of self-care interventions suggested for children and young people with anxiety and depression has not been evaluated, new research shows.
Greater depressive and anxiety symptoms at baseline predicted a better response to treatment with synchronized transcranial magnetic stimulation (sTMS) for major depressive disorder (MDD), according to a study.
Older adults who are prescribed medication for depression by primary care physicians often fail to initiate them or to continue using them as directed, a Dutch study suggests.
Adjunctive testosterone treatment in men is associated with a significant drop in depressive symptoms, compared with placebo, according to a systematic review and meta-analysis published online in JAMA Psychiatry.
More frequent in-person social interaction is linked with a significantly lower risk of symptoms of major depression and posttraumatic stress disorder (PTSD) in US military veterans, according to a study published online.
BLOG: This year’s Psych Congress returned, time and again, to the theme of us needing to reconnect with a larger experience of the world in order to find a path out of depression.
BLOG: The logical endpoint of population-based screening for perinatal depression is remission of depression in those who screen positive. Otherwise screening is just an empty endeavor.
Psych Congress cochair Charles Raison, MD, recently discussed his research and perspectives in an extensive interview with Rhonda Perciavalle Patrick, PhD, who runs the FoundMyFitness website.
Saundra Jain, MA, PsyD, LPC, a Psych Congress Steering Commitee member, explains the Patient Health Questionnaire (PHQ-9), the gold standard measurement tool in major depression.
Mary Kay Lobo, PhD, an assistant professor at the University of Maryland School of Medicine, Baltimore, explains research which suggests a specific gene, Slc6a15, may be central to depression.
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.